Author:
Acar Emine,Bekiş Recep,Polack Berna
Publisher
Springer International Publishing
Reference95 articles.
1. Türkiye Kanser İstatistikleri. 2017.; http://kanser.gov.tr/Dosya/ca_istatistik/2014-RAPOR._uzuuun.pdf.
2. Mottet N, van den Bergh RC, Briers E, et al. EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer-2020 update. Part 1: Screening, diagnosis, and local treatment with curative ıntent. Eur Urol. 2021;79(2):243–62.
3. Ahmadzadehfar H, Eppard E, Kurpig S, et al. Therapeutic response and side effects of repeated radioligand therapy with 177Lu-PSMA-DKFZ-617 of castrate-resistant metastatic prostate cancer. Oncotarget. 2016;7(11):12477–88.
4. Prostate Cancer Version 2. 2017. NCCN Clin Pract Guidelines Oncol 2017.
5. Attard G, Parker C, Eeles RA, et al. Prostate cancer. Lancet (London, England). 2016;387(10013):70–82.